Superficial heat-cold application improves sleep quality in RLS patients, with optimal results at 42.5°C for 10 minutes. RLS affects 5% to 10% of US adults, causing sleep disturbances and impacting ...
Add Yahoo as a preferred source to see more of our stories on Google. You’ve just settled into bed for the night, when an uncomfortable sensation creeps up your legs. Suddenly, you feel a strong urge ...
We found that PCDs effectively improved the symptoms associated with RLS. While a placebo effect was observed, therapeutic PCDs resulted in significantly greater improvements in disease severity, ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo status to the NTX100 Tonic Motor Activation System for patients with moderate to severe, ...
Dual feature in the prestigious, peer-reviewed journal, Sleep show that TOMAC therapy was safe and effective in adults with RLS refractory to medications, with all primary and secondary endpoints ...
PLEASANTON, Calif., April 19, 2023 /PRNewswire/ -- Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation ...
Background: Pharmacotherapy for restless legs syndrome (RLS) may be ineffective or complicated by side effects. Uncontrolled series using pneumatic compression devices (PCDs) have been shown to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results